Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
G
340450
vs
K
KOSPI 200
Over the past 12 months, GC Genome Corp has significantly outperformed KOSPI 200, delivering a return of +103% compared to KOSPI 200's +53% growth.
Stocks Performance
340450 vs KOSPI 200
Performance Gap
340450 vs KOSPI 200
Performance By Year
340450 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
GC Genome Corp
Glance View
GC Genome Corp. is a clinical genome analysis company, which engages in specializing clinical genome analysis. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 131 full-time employees. The company went IPO on 2025-06-11. The firm is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.